“These are the countries of South America, Africa, Arab countries.
Interest in the drug only intensified after they began to publish reports confirming the effectiveness of this drug, "RIA Novosti quotes him.
According to a representative of the manufacturing company, Brazil, Iraq, Egypt, Spain, Mexico, Peru, Saudi Arabia, Lebanon, India, Syria, United Arab Emirates, Saudi Arabia, Qatar, Iran, Colombia are interested in deliveries of Areplivir , Argentina, Chile, Ecuador, Paraguay, Macedonia, Slovenia, Bulgaria and South Africa.
Earlier it was reported that Russia stopped the sale of Areplivir abroad due to high domestic demand.